Concepedia

Ian T. Huscroft

IT

Statistics

Publications

9

Citations

536

H-Index

9

Active since

1995

Affiliations

MSD (UK) Limited (United Kingdom)(Current)

Merck & Co., Inc., Rahway, NJ, USA (United States)

Ian T. Huscroft is an author at MSD (UK) Limited (United Kingdom) specializing in pharmacology, medicine, and pharmacotherapy.

Top concepts

Publications per year

1995–2006

9

Publications

9

Genetic knockout and pharmacological blockade studies of the 5-HT7 receptor suggest therapeutic potential in depression

Martin R. Guscott, Linda J. Bristow, Karen L. Hadingham et al. · Neuropharmacology · 2005 · 227 citations

, , +12

In vitro and in vivo predictors of the anti-emetic activity of tachykinin NK1 receptor antagonists

N.M.J. Rupniak, F.D. Tattersall, Angela Williams et al. · European Journal of Pharmacology · 1997 · 117 citations

, , +8

Modulation of [3H]MK-801 binding to NMDA receptors in vivo and in vitro

Fraser Murray, Jeffrey D. Kennedy, Peter H. Hutson et al. · European Journal of Pharmacology · 2000 · 57 citations

, , +8

4,4-Disubstituted Piperidine High-Affinity NK<sub>1</sub> Antagonists:  Structure−Activity Relationships and <i>in Vivo</i> Activity

Graeme I. Stevenson, Ian T. Huscroft, Angus M. MacLeod et al. · Journal of Medicinal Chemistry · 1998 · 29 citations · Full text

, , +16

1-Phenyl-8-azabicyclo[3.2.1]octane ethers: A novel series of neurokinin (NK1) antagonists

Ian T. Huscroft, Emma Carlson, Gary G. Chicchi et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 26 citations · Full text

, , +6

1–5 of 9